Axsome Therapeutics, Inc. · NASDAQ:AXSM

BlackRock, Inc. reported a 5.30% stake in Axsome Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 27, 2026

BlackRock, Inc. reported a 5.30% stake in Axsome Therapeutics, Inc., 2,736,503 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).

Stake
5.30%
Shares
2,736,503
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.5.30%2,736,503

Source

View original at SEC

Related